This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $826,902 to the Hugo W. Moser Research Institute at Kennedy Krieger, Inc. to examine the dynamic relationships between physical activity, sleep, and circadian rhythms with heterogeneity in clinical symptoms and neurobehavioral functioning in children with Attention-Deficit/Hyperactivity Disorder (ADHD). The 5-year project aims to leverage...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $809,312 to Duke University to characterize circadian function and sleep disturbances among 250 children with Attention-Deficit/Hyperactivity Disorder (ADHD). The study aims to: 1) Assess individual differences in circadian function and sleep profiles using laboratory-based dim light melatonin onset (DLMO) testing and wearable sensors; 2) Examine...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under CFDA program 93.242 Mental Health Research Grants, aims to develop an integrated, portable sensor suite to track neural activity, physiological arousal, motor signals, and physical interactions in social environments. The $764,476 award, spanning June 2025 to May 2028, will enable the University of California, Los Angeles (UCLA) to: Optimize the synchronization and portability of the sensor system,...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $449,729 to Openmindxr LLC to develop a suite of virtual reality (VR) programs that address social skills deficits in youth with ADHD. The funded project aims to create three distinct VR modules: "PerspectiveR" to help users understand the thoughts and feelings of others, "Social Skills Challenge" to identify and practice...
This $1,309,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program supports the development of a novel digital psychiatry diagnostic framework that utilizes crowdsourcing algorithms to improve the specificity of machine learning models in distinguishing between autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in adolescents. The key products and services to be delivered under this 3-year...
The National Institute of Mental Health (NIMH) awarded a 5-year, $857,216 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Boston Children's Hospital to conduct longitudinal research on the neurodevelopmental trajectories leading to early attention deficit hyperactivity disorder (ADHD) and disruptive behaviors (DBs) in young children. The study will leverage an existing NINDS-funded sample of low-resourced, racially and ethnically diverse infants, collecting electroencephalogram...
This $174,788 National Science Foundation (NSF) award under the Computer and Information Science and Engineering (CISE) program focuses on enhancing the assessment and diagnosis of Attention Deficit Hyperactivity Disorder (ADHD). The project aims to develop computational approaches to collect and analyze ADHD-related data, leveraging technologies such as inertial movement units, touch-sensitive screens, and high-precision cameras to gather insights into hyperactivity behaviors. The goal is to...
This Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), is focused on developing an advanced technology for non-invasive recording of whole-brain physiology with synchronized video-tracking of movement. The total award amount is $6,311,402.00, with a project period from July 2024 to April 2026. The award has three key objectives: 1) refine and validate the use of a wearable optically-pumped magnetometer...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $671,533 to fund research on using accelerated intermittent theta-burst transcranial magnetic stimulation (iTBS) to target the pre-supplementary motor area (pre-SMA) in adolescents with Attention Deficit Hyperactivity Disorder (ADHD). The two-phase project aims to modulate inhibitory network biomarkers (R61 phase) and evaluate the effects of...
Tanzen Medical, Inc. was awarded a $486,552 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to develop RESTEAZE, a wearable device and mobile application designed to improve the diagnosis and management of restless legs syndrome (RLS) in pediatric patients with attention deficit/hyperactivity disorder (ADHD). The RESTEAZE system aims to provide objective measurements of leg movements during sleep as a biomarker for...